FSMAX | KMVAX | FSMAX / KMVAX | |
Total Expense Ratio | 0.04 | 1.35 | 3% |
Annual Report Gross Expense Ratio | 0.04 | 1.35 | 3% |
Fund Existence | 14 years | 27 years | - |
Gain YTD | 10.860 | 19.511 | 56% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 41.4B | 115M | 36,000% |
Annual Yield % from dividends | 0.44 | 0.00 | - |
Returns for 1 year | 12.72 | 12.54 | 101% |
Returns for 3 years | 63.57 | 68.96 | 92% |
Returns for 5 years | 48.84 | 89.07 | 55% |
Returns for 10 years | 103.74 | 70.53 | 147% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PHPSX | 23.06 | 0.10 | +0.44% |
ProFunds Pharmaceuticals UltraSector Svc | |||
LMPEX | 28.53 | 0.10 | +0.35% |
Franklin Global Equity 1 | |||
FBSOX | 50.53 | N/A | N/A |
Fidelity Select Enterprise Tech Svcs | |||
AMIDX | 15.28 | N/A | N/A |
Amana Developing World Institutional | |||
KAUAX | 6.17 | -0.01 | -0.16% |
Federated Hermes Kaufmann A |